The long-term stocks had a rougher week, although the prices did not change much as a percentage of the large sum invested. Much of the large gain from last week was eaten by the decline of the week end price of every single stock. Pfizer lost the least, losing a single cent of its close the prior Friday. Baxter lost the most in dollars, losing 33 cents per share over the close last week. The portfolio lost much of its gains from the prior week, but still is worth $326.84 more than when it was purchased.